Sonoma Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Sonoma Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2011 to Q3 2024.
  • Sonoma Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -26 %, a 36.9% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Return On Assets for 2023 was -31.1 %, a 8.72% decline from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Return On Assets for 2022 was -28.6 %, a 2.49% increase from 2021.
  • Sonoma Pharmaceuticals, Inc. annual Return On Assets for 2021 was -29.3 %, a 18.9% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -26 +15.2 +36.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -32.2 +5.06 +13.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -32.8 +0.24 +0.73% Jan 1, 2024 Mar 31, 2024
Q4 2023 -33.6 +8.21 +19.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -41.2 -8.26 -25.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.3 -11.3 -43.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -33.1 -4.88 -17.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -41.8 -7.85 -23.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -33 -0.15 -0.46% Jul 1, 2022 Sep 30, 2022
Q2 2022 -25.9 +6.36 +19.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -28.2 -5.45 -24% Jan 1, 2022 Mar 31, 2022
Q4 2021 -34 -22.3 -189% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.8 -18.2 -124% Jul 1, 2021 Sep 30, 2021
Q2 2021 -32.3 -9.12 -39.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.8 -2.12 -10.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -11.7 +18.2 +60.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -14.6 +22.6 +60.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -23.2 +25.4 +52.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -20.6 +54.9 +72.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -30 +49.4 +62.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -37.2 +45.8 +55.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -48.6 +28.2 +36.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -75.5 -4.02 -5.62% Jan 1, 2019 Mar 31, 2019
Q4 2018 -79.4 -23.8 -42.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -83 -114 -368% Jul 1, 2018 Sep 30, 2018
Q2 2018 -76.8 -116 -295% Apr 1, 2018 Jun 30, 2018
Q1 2018 -71.5 -122 -242% Jan 1, 2018 Mar 31, 2018
Q4 2017 -55.6 -112 -198% Oct 1, 2017 Dec 31, 2017
Q3 2017 31 +122 Jul 1, 2017 Sep 30, 2017
Q2 2017 39.4 +121 Apr 1, 2017 Jun 30, 2017
Q1 2017 50.5 +126 Jan 1, 2017 Mar 31, 2017
Q4 2016 56.9 +121 Oct 1, 2016 Dec 31, 2016
Q3 2016 -91.1 -6.78 -8.05% Jul 1, 2016 Sep 30, 2016
Q2 2016 -81.8 -11.4 -16.1% Apr 1, 2016 Jun 30, 2016
Q1 2016 -75.7 -25.4 -50.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -63.7 -68 -1596% Oct 1, 2015 Dec 31, 2015
Q3 2015 -84.3 -119 -340% Jul 1, 2015 Sep 30, 2015
Q2 2015 -70.4 -107 -294% Apr 1, 2015 Jun 30, 2015
Q1 2015 -50.4 -80.2 -269% Jan 1, 2015 Mar 31, 2015
Q4 2014 4.26 +63.2 Oct 1, 2014 Dec 31, 2014
Q3 2014 35.2 +103 Jul 1, 2014 Sep 30, 2014
Q2 2014 36.2 +99 Apr 1, 2014 Jun 30, 2014
Q1 2014 29.8 +75.6 Jan 1, 2014 Mar 31, 2014
Q4 2013 -58.9 -14.4 -32.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -68.1 -14.1 -26.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -62.8 -7.8 -14.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -45.8 +41 +47.3% Jan 1, 2013 Mar 31, 2013
Q4 2012 -44.5 +39.4 +46.9% Oct 1, 2012 Dec 31, 2012
Q3 2012 -54 Jul 1, 2012 Sep 30, 2012
Q2 2012 -55 Apr 1, 2012 Jun 30, 2012
Q1 2012 -86.8 Jan 1, 2012 Mar 31, 2012
Q4 2011 -83.8 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.